NN

Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI) at PEGS Europe 2026

Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website

Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI) brings 4 presentations to PEGS Europe 2026 in Lisbon. Its program centres on computational protein design and AI in the lab, including best practice for designing antibodies in silico and the appropriate use of agentic AI. It also presents de novo designed binders of peptide-MHC complexes that direct T cells to kill cancer cells.

OrganizationPEGS Europe 2026 Attendance
NN
Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI)
Talk
Tue Nov 17
2:05pm–2:35pm
Panel
Tue Nov 17
5:50pm–6:20pm
BEST PRACTICES FOR IN SILICO DESIGN OF ANTIBODIES: What We Know Now
Display of Biologics · with AstraZeneca, Specifica, Merck KGaA
Chair
Thu Nov 19
2:00pm–2:05pm
Chairperson's Remarks
Machine Learning for Protein Engineering Part 2
Panel
Thu Nov 19
3:36pm–4:14pm
Appropriate Use of Agentic AI in the Lab
Machine Learning for Protein Engineering Part 2 · with Specifica

Explore the full PEGS Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Lisbon. Leave your work email and we’ll be in touch.

Privacy

Download the full PEGS Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI)

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction